Advertisement

Alterations in Nerve Growth Factor Receptor Containing Neurons in Parkinson’s Disease

  • Elliott J. Mufson
  • Lesa N. Presley
  • Gerald A. Higgins
  • Jeffrey H. Kordower
Part of the Advances in Behavioral Biology book series (ABBI, volume 38A)

Abstract

At the turn of the century, neuronal loss associated with the nucleus basalis of Meynert was first observed in patients with Parkinson’s disease (PD) by Lewy1. Neuronal loss in this region has been based primarily on material stained for Nissl substance using perikaryal diameter as the criterion for including a neuron as part of the nucleus basalis2,3. The caveats associated with such investigations have been discussed in detail, elsewhere4. The magnocellular neurons of the nucleus basalis (Ch4) have been shown to contain the specific cholinergic marker choline acetyltransferase (ChAT)5,6,7, and that these cell bodies provide the major cholinergic innervation of the neocortex and amygdala5,8. Degeneration of these neurons may underlie deficits in cognition often seen in Alzheimer’s and Parkinson’s disease9,10 and that these cell bodies also are under the influence of the trophic substance nerve growth factor (NGF)11. We have shown using antibodies for the NGF receptor (NGFR) an almost complete colocalization between neurons expressing NGFR and the cholinergic marker ChAT within the human nucleus basalis7. Thus, the characterization of an antibody which visualizes the primate NGFR6,7 provides a unique probe for assessing the integrity of nucleus basalis cholinergic neurons in human disease. In this chapter, we present evidence of basal forebrain neuronal dysfunction in neurons which localize the NGFR without AD-type pathology in patients with PD.

Keywords

Basal Forebrain Nucleus Basalis Nerve Growth Factor Receptor Magnocellular Neuron Cholinergic Marker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F.H. Lewy, Zur pathologischen Anatomie der Pralysis agitans, Dtsch Z Nervenheilkd, 50: 50 (1913).Google Scholar
  2. 2.
    P. Gaspar and F. Gray, Dementia in idiopathic Parkinson’s disease, Acta Neuropath. 64: 43 (1984).PubMedCrossRefGoogle Scholar
  3. 3.
    P.J. Whitehouse, Chemical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson’s disease and Alzheimer’s disease, in: “Advances in Neurology”, M.D. Yahr and K.J. Bergmann, eds., Raven Press, NY (1986).Google Scholar
  4. 4.
    E.J. Mufson, M. Bothwell, and J.H. Kordower, Loss of nerve growth factor receptor-containing neurons in Alzheimer’s disease’: A quantitative analysis across subregions of the basal forebrain, Exp. Neurol., 105: 221 (1989).PubMedCrossRefGoogle Scholar
  5. 5.
    M.M. Mesulam, E.J. Mufson, A.I. Levey, and B.H. Wainer, Cholinergic innervation of cortex by basal forebrain. Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the Rhesus monkey, J. Comp. Neurol. 214: 170 (1983).PubMedCrossRefGoogle Scholar
  6. 6.
    J.H. Kordower, R.T. Bartus, M. Bothwell, G. Schatteman, and D.M. Gash, Nerve growth factor immunoreactivity in the non-human primate (Cebus appella): Distribution, morphology, and co-localization with cholinergie enzymes, J. Comp. Neurol. 277: 465 (1988).PubMedCrossRefGoogle Scholar
  7. 7.
    E.J. Mufson, M. Bothwell, L.B. Hersh, and J.H. Kordower, Nerve growth factor receptor immunoreactive profiles in the normal aged human basal forebrain: Colocalization with cholinergie neurons, J. Comp. Neurol. 285: 196 (1989).PubMedCrossRefGoogle Scholar
  8. 8.
    J.H. Kordower, R.T. Bartus, F.E. Marriano, and D.M. Gash, Telencephalic cholinergie system of the new world monkey (cebus appella): Morphologic assessment and analysis of the projection to amygdala, J. Comp. Neurol. 279: 528 (1989).CrossRefGoogle Scholar
  9. 9.
    P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle, and M.R. DeLong, Alzheimer’s disease and senile dementia: Loss of neurons in the basal forebrain, Science 215: 1237 (1982).PubMedCrossRefGoogle Scholar
  10. 10.
    F. Hefti, W.J. Weiner, Nerve growth factor and Alzheimer’s disease, Ann. Neurol. 20: 275 (1986).PubMedCrossRefGoogle Scholar
  11. 11.
    S.R. Whitemore and A. Seiger, The expression, colocalization and functional significance of B-nerve growth factor in the central nervous system, Brain Res. Rev. 12: 439 (1987).CrossRefGoogle Scholar
  12. 12.
    J.H. Kordower, D.M. Gash, M.A. Bothwell, L.B. Hersh, and E.J. Mufson, Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer’s patients, Neurolbiol. Aging 10: 67 (1989).Google Scholar
  13. 13.
    E.J. Mufson, D.C. Mash, and L.B. Hersh, Neurofibrillary tangles in cholinergie pedunculopontine neurons in Alzheimer’s disease, Ann. Neurol. 24: 623 (1988).PubMedCrossRefGoogle Scholar
  14. 14.
    G.A. Higgins and E.J. Mufson, NGF receptor gene expression is decreased in the nucleus basais in Alzheimer’s disease, Exp. Neurol., in press.Google Scholar
  15. 15.
    M.M. Mesulam and M.A. Moran, Cholinesterase within neurofibrillary tangles related to age and Alzheimer’s disease, Ann. Neurol. 22: 223 (1987).PubMedCrossRefGoogle Scholar
  16. 16.
    C.A. Kitt, D. Price, B. Wainer, M. Becher, and W. Mobley, Evidence for cholinergie neurites in senile plaques, Science 226: 1443 (1984).PubMedCrossRefGoogle Scholar
  17. 17.
    S.M. de la Monte, S.W. Wells, E. Tesa Hedley-White, and J.H. Growdon, Neuropathological destruction between Parkinson’s dementia and Parkinson’s plus Alzheimer’s disease, Ann. Neurol. 26: 309 (1989).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Elliott J. Mufson
    • 1
  • Lesa N. Presley
    • 1
  • Gerald A. Higgins
    • 2
  • Jeffrey H. Kordower
    • 3
  1. 1.Christopher Center for Parkinson’s ResearchInstitute for Biogerontology ResearchSun CityUSA
  2. 2.Department of Neurobiology and AnatomyUniversity of Rochester Medical CenterRochesterUSA
  3. 3.Department of Anatomy and Cell BiologyUniversity of Illinois School of Medicine ChicagoUSA

Personalised recommendations